RANKL Synthesized by Both Stromal Cells and Cancer Cells Plays a Crucial Role in Osteoclastic Bone Resorption Induced by Oral Cancer
Kiyoshi Sato(Tokyo Medical and Dental University), Akira Yamaguchi(Tokyo Dental College), Masanobu Shindoh(Hokkaido University), Tadahiro Iimura(Wayne State University), Hisataka Yasuda(SHOWA Medical University), Ji‐Won Lee(Chubu University), Masako Ito(Nagasaki University), Kei Sakamoto(University of Copenhagen), Ken Omura(Ebina General Hospital), Kou Kayamori(Tokyo Medical and Dental University)
Cited by 28
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
|Biochemical and Biophysical Research Communications|1998|746